Vanessa Schelfhout

423 total citations
21 papers, 309 citations indexed

About

Vanessa Schelfhout is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Vanessa Schelfhout has authored 21 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Physiology. Recurrent topics in Vanessa Schelfhout's work include Asthma and respiratory diseases (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Medical Imaging Techniques and Applications (4 papers). Vanessa Schelfhout is often cited by papers focused on Asthma and respiratory diseases (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Medical Imaging Techniques and Applications (4 papers). Vanessa Schelfhout collaborates with scholars based in Belgium, Spain and Netherlands. Vanessa Schelfhout's co-authors include Guy Joos, Ruben Pauwels, Romain Pauwels, Walter Vincken, Jianhui Wang, Renaud Louis, Michael J. Shaw, Giovanni Della Cioppa, Reinilde Heyrman and Renaud Louis and has published in prestigious journals such as Neurology, Annals of the New York Academy of Sciences and European Respiratory Journal.

In The Last Decade

Vanessa Schelfhout

20 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Schelfhout Belgium 12 156 140 56 43 40 21 309
Paola Bini Italy 12 50 0.3× 102 0.7× 22 0.4× 21 0.5× 75 1.9× 43 391
Hisae Mori Japan 9 92 0.6× 34 0.2× 27 0.5× 22 0.5× 47 1.2× 41 342
A. Artlich Germany 14 266 1.7× 230 1.6× 41 0.7× 9 0.2× 81 2.0× 24 491
Himender Makker United Kingdom 7 320 2.1× 259 1.9× 11 0.2× 47 1.1× 34 0.8× 9 527
Hideyuki Yamauchi Japan 6 137 0.9× 127 0.9× 77 1.4× 5 0.1× 93 2.3× 9 305
K. Ohara Japan 8 57 0.4× 147 1.1× 39 0.7× 9 0.2× 66 1.6× 18 399
Maria Ricci Italy 12 83 0.5× 69 0.5× 19 0.3× 122 2.8× 40 1.0× 41 365
Caroline Dixon United Kingdom 8 97 0.6× 147 1.1× 116 2.1× 4 0.1× 73 1.8× 14 293
Kazuya Tanase Japan 11 138 0.9× 26 0.2× 16 0.3× 64 1.5× 26 0.7× 28 349
Andreas Faulstich Germany 7 55 0.4× 23 0.2× 40 0.7× 32 0.7× 36 0.9× 9 494

Countries citing papers authored by Vanessa Schelfhout

Since Specialization
Citations

This map shows the geographic impact of Vanessa Schelfhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Schelfhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Schelfhout more than expected).

Fields of papers citing papers by Vanessa Schelfhout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Schelfhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Schelfhout. The network helps show where Vanessa Schelfhout may publish in the future.

Co-authorship network of co-authors of Vanessa Schelfhout

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Schelfhout. A scholar is included among the top collaborators of Vanessa Schelfhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Schelfhout. Vanessa Schelfhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauters, Wouter, David Creytens, Liesbeth Ferdinande, et al.. (2024). Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma. EJNMMI Research. 14(1). 82–82. 1 indexed citations
2.
Struelens, Lara, Else A. Aalbersberg, Laurence Beels, et al.. (2024). How much do 68Ga-, 177Lu- and 131I-based radiopharmaceuticals contribute to the global radiation exposure of nuclear medicine staff?. EJNMMI Physics. 11(1). 95–95. 1 indexed citations
3.
Creytens, David, Philippe Deron, Benedicte Descamps, et al.. (2023). Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2127–2139. 5 indexed citations
4.
Man, Kathia De, Louke Delrue, Valérie Fonteyne, et al.. (2022). Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging. Molecular Imaging and Biology. 24(5). 750–758. 3 indexed citations
5.
Man, Kathia De, Vanessa Schelfhout, Wolfgang P. Fendler, et al.. (2022). 18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial. European Urology. 82(5). 501–509. 23 indexed citations
6.
Schelfhout, Vanessa, Liève Brochez, David Creytens, et al.. (2021). High-Resolution 18F-FDG PET/CT for Assessing Three-Dimensional Intraoperative Margins Status in Malignancies of the Head and Neck, a Proof-of-Concept. Journal of Clinical Medicine. 10(16). 3737–3737. 14 indexed citations
7.
Creytens, David, Liève Brochez, Yves D’Asseler, et al.. (2021). Three-dimensional margin assessment in head and neck malignancies using a submillimetric 18F-FDG PET/CT, results of an ongoing clinical trial. Oral Oncology. 118. 5–5. 1 indexed citations
8.
Man, Kathia De, Vanessa Schelfhout, Ken Kersemans, et al.. (2020). Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer. EJNMMI Research. 10(1). 14–14. 14 indexed citations
9.
Schelfhout, Vanessa, Josep M. Jansat, Francesc Peris, et al.. (2010). Activity of aclidinium bromide, a new long‐acting muscarinic antagonist: a phase I study. British Journal of Clinical Pharmacology. 69(5). 458–464. 13 indexed citations
10.
Schelfhout, Vanessa, et al.. (2010). Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature. Gynecologic and Obstetric Investigation. 70(3). 186–191. 13 indexed citations
11.
Joos, Guy, Vanessa Schelfhout, Ruben Pauwels, et al.. (2009). Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respiratory Medicine. 104(6). 865–872. 27 indexed citations
12.
Endeman, Henrik, Vanessa Schelfhout, G. Paul Voorn, et al.. (2008). Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scandinavian Journal of Infectious Diseases. 40(9). 715–720. 27 indexed citations
13.
Schelfhout, Vanessa, Vera Van de Velde, Ruben Pauwels, & Guy Joos. (2007). The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma—A comparison with leukotriene D4 induced broncoconstriction. Pulmonary Pharmacology & Therapeutics. 21(2). 276–284. 10 indexed citations
14.
Derom, Eric, et al.. (2007). Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. Respiratory Medicine. 101(9). 1931–1941. 27 indexed citations
15.
Coosemans, An, Silvia Caluwaerts, L. Verbist, et al.. (2006). UPREGULATION OF WILMS' TUMOR GENE 1 (WT1) IN UTERINE SARCOMAS. International Journal of Gynecological Cancer. 16. 768–769.
16.
Schelfhout, Vanessa, Renaud Louis, Werner Lenz, et al.. (2005). The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulmonary Pharmacology & Therapeutics. 19(6). 413–418. 28 indexed citations
17.
Joos, Guy, et al.. (2003). The Role of Neural Inflammation in Asthma and Chronic Obstructive Pulmonary Disease. Annals of the New York Academy of Sciences. 992(1). 218–230. 35 indexed citations
18.
Joos, Guy, Walter Vincken, Renaud Louis, et al.. (2003). Dual tachykinin NK1/NK2antagonist DNK333 inhibits neurokinin A‐induced bronchoconstriction in asthma patients. European Respiratory Journal. 23(1). 76–81. 49 indexed citations
19.
Smets, Koenraad, Vanessa Schelfhout, C. R. De Potter, & Piet Vanhaesebrouck. (1999). Early prediction of chronic lung disease by tracheal aspirate cytology in ventilated newborns. European Journal of Pediatrics. 158(3). 234–237. 3 indexed citations
20.
Bleecker, Jan De, et al.. (1999). Melatonin and painful gynecomastia. Neurology. 53(2). 435–435. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Bini Breakdown of academic impact, for papers by Hisae Mori Breakdown of academic impact, for papers by A. Artlich Breakdown of academic impact, for papers by Himender Makker Breakdown of academic impact, for papers by Hideyuki Yamauchi Breakdown of academic impact, for papers by K. Ohara Breakdown of academic impact, for papers by Maria Ricci Breakdown of academic impact, for papers by Caroline Dixon Breakdown of academic impact, for papers by Kazuya Tanase Breakdown of academic impact, for papers by Andreas Faulstich
Rankless by CCL
2026